262 related articles for article (PubMed ID: 12209690)
1. Salvage combination chemotherapy with 5-fluorouracil and actinomycin D for patients with refractory, high-risk gestational trophoblastic tumors.
Matsui H; Suzuka K; Iitsuka Y; Yamazawa K; Tanaka N; Mitsuhashi A; Seki K; Sekiya S
Cancer; 2002 Sep; 95(5):1051-4. PubMed ID: 12209690
[TBL] [Abstract][Full Text] [Related]
2. Salvage chemotherapy for high-risk gestational trophoblastic tumor.
Matsui H; Iitsuka Y; Suzuka K; Yamazawa K; Mitsuhashi A; Sekiya S
J Reprod Med; 2004 Jun; 49(6):438-42. PubMed ID: 15283050
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
Wang S; An R; Han X; Zhu K; Xue Y
Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237
[TBL] [Abstract][Full Text] [Related]
5. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
6. Management of resistant gestational trophoblastic tumors.
Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
[TBL] [Abstract][Full Text] [Related]
7. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
8. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Dobson LS; Lorigan PC; Coleman RE; Hancock BW
Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
[TBL] [Abstract][Full Text] [Related]
9. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
[TBL] [Abstract][Full Text] [Related]
10. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
11. Management of drug resistant gestational trophoblastic neoplasia.
Patel SM; Desai A
J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
[TBL] [Abstract][Full Text] [Related]
12. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
Soto-Wright V; Goldstein DP; Bernstein MR; Berkowitz RS
Gynecol Oncol; 1997 Jan; 64(1):156-9. PubMed ID: 8995566
[TBL] [Abstract][Full Text] [Related]
13. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
14. High-risk metastatic gestational trophoblastic tumors. Current management.
Lurain JR
J Reprod Med; 1994 Mar; 39(3):217-22. PubMed ID: 7518518
[TBL] [Abstract][Full Text] [Related]
15. Placental site trophoblastic tumor: an overview.
Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; Cantú MG
J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
[TBL] [Abstract][Full Text] [Related]
16. Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.
Cyriac S; Rajendranath R; Sridevi V; Sagar TG
J Reprod Med; 2011; 56(5-6):219-23. PubMed ID: 21682117
[TBL] [Abstract][Full Text] [Related]
17. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Lurain JR; Nejad B
Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
[TBL] [Abstract][Full Text] [Related]
18. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Surwit EA; Childers JM
J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
[TBL] [Abstract][Full Text] [Related]
19. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.
Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P
J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348
[TBL] [Abstract][Full Text] [Related]
20. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
